| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018286 |
| Receipt No. | R000021166 |
| Official scientific title of the study | Preliminary study on the effect of the fish-derived component containing beverages on body fat in human |
| Date of disclosure of the study information | 2015/07/21 |
| Last modified on | 2016/07/20 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Preliminary study on the effect of the fish-derived component containing beverages on body fat in human | |
| Title of the study (Brief title) | Preliminary study on the effect of the fish-derived component containing beverages on body fat in human | |
| Region |
|
|
| Condition | ||
| Condition | obesity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect and safety of the fish-derived component containing beverages on body fat in human. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Abdominal total fat area |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Fish-derived component containing beverage (low dose), 12 Weeks | |
| Interventions/Control_2 | Fish-derived component containing beverage (high dose), 12 Weeks | |
| Interventions/Control_3 | No fish-derived component containing beverage, 12 Weeks | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Subject who is 20 years of age or older.
2) Subject, 25 kg/m2 <= BMI < 30 kg/m2. 3) Subject who is able to give written informed consent before the study. |
|||
| Key exclusion criteria | 1) Subject receiving continuous medical treatment.
2) Subject with present disease such as liver disorder, kidney disorder, cardiac affection, diabetes mellitus. 3) Subject taking medication or functional foods, influencing the result of this study, such as medicine, food for specified health use, food with function claims supplement, diet food. 4) Subject with drug or food allergy 5) Female subject in pregnancy, lactation or intending to become pregnant during the study. 6) Subject deemed unsuitable by the investigator. |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Junichi Nakamura |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0460 |
| Junichi_Nakamura@suntory.co.jp | |
| Public contact | |
| Name of contact person | Kayo Saito |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan |
| TEL | 050-3182-0527 |
| Homepage URL | |
| Kayo_Saito@suntory.co.jp | |
| Sponsor | |
| Institute | QOL RD Co.,Ltd. |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Suntory Beverage & Food Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021166 |